The effect of mirabegron on patient-related outcomes in patients with overactive bladder: the results of post hoc correlation and responder analyses using pooled data from three randomized Phase III trials
about
CUA guideline on adult overactive bladderMirabegron for the treatment of overactive bladder: a review of efficacy, safety and tolerability with a focus on male, elderly and antimuscarinic poor-responder populations, and patients with OAB in Asia.Mirabegron.Mirabegron improves quality-of-life, treatment satisfaction, and persistence in patients with overactive bladder: a multi-center, non-interventional, real-world, 12-month study.Combination treatment with mirabegron and solifenacin in patients with overactive bladder: exploratory responder analyses of efficacy and evaluation of patient-reported outcomes from a randomized, double-blind, factorial, dose-ranging, Phase II studPatient-reported outcomes in patients with overactive bladder treated with mirabegron and tolterodine in a prospective, double-blind, randomized, two-period crossover, multicenter study (PREFER).
P2860
The effect of mirabegron on patient-related outcomes in patients with overactive bladder: the results of post hoc correlation and responder analyses using pooled data from three randomized Phase III trials
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
The effect of mirabegron on pa ...... ee randomized Phase III trials
@ast
The effect of mirabegron on pa ...... ee randomized Phase III trials
@en
type
label
The effect of mirabegron on pa ...... ee randomized Phase III trials
@ast
The effect of mirabegron on pa ...... ee randomized Phase III trials
@en
prefLabel
The effect of mirabegron on pa ...... ee randomized Phase III trials
@ast
The effect of mirabegron on pa ...... ee randomized Phase III trials
@en
P2093
P2860
P1476
The effect of mirabegron on pa ...... ee randomized Phase III trials
@en
P2093
C R Chapple
D Castro-Diaz
L Delgado-Herrera
M B Blauwet
P2860
P2888
P304
P356
10.1007/S11136-014-0904-4
P577
2015-02-17T00:00:00Z